BlackRock Fund Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $256K | Buy |
7,769
+207
| +3% | +$6.82K | ﹤0.01% | 3361 |
|
|
2016
Q3 | $310K | Sell |
7,562
-21
| -0.3% | -$861 | ﹤0.01% | 3321 |
|
|
2016
Q2 | $249K | Sell |
7,583
-63,551
| -89% | -$2.09M | ﹤0.01% | 3384 |
|
|
2016
Q1 | $4.41M | Sell |
71,134
-1,210
| -2% | -$74.9K | ﹤0.01% | 2808 |
|
|
2015
Q4 | $3.05M | Buy |
72,344
+1,907
| +3% | +$80.4K | ﹤0.01% | 3037 |
|
|
2015
Q3 | $3.86M | Buy |
70,437
+9,244
| +15% | +$507K | ﹤0.01% | 2927 |
|
|
2015
Q2 | $6.72M | Buy |
61,193
+42,329
| +224% | +$4.65M | ﹤0.01% | 2743 |
|
|
2015
Q1 | $1.79M | Buy |
18,864
+5,287
| +39% | +$502K | ﹤0.01% | 3154 |
|
|
2014
Q4 | $760K | Buy |
13,577
+1,867
| +16% | +$105K | ﹤0.01% | 3234 |
|
|
2014
Q3 | $848K | Sell |
11,710
-483
| -4% | -$35K | ﹤0.01% | 3200 |
|
|
2014
Q2 | $1.83M | Sell |
12,193
-1,137
| -9% | -$171K | ﹤0.01% | 3131 |
|
|
2014
Q1 | $1.94M | Buy |
+13,330
| New | +$1.94M | ﹤0.01% | 3141 |
|